Evidence map›Paper›PMID 27175152›Full record

ArticleIranian journal of veterinary research2015

Effects of Saccharomyces cerevisiae on survival rate and growth performance of Convict Cichlid (Amatitlania nigrofasciata).

F Mohammadi, S M Mousavi, E Ahmadmoradi, M Zakeri, A Jahedi

Abstract read
In one paragraph

Article in Iranian journal of veterinary research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

F MohammadiGraduated from Faculty of Marine Natural Resources, Khorramshahr University of Marine Science and Technology, Khorramshahr, Iran;
S M MousaviDepartment of Fisheries, Faculty of Marine Natural Resources, Khorramshahr University of Marine Science and Technology, Khorramshahr, Iran;
E AhmadmoradiGraduated from Faculty of Marine Natural Resources, Khorramshahr University of Marine Science and Technology, Khorramshahr, Iran;
M ZakeriDepartment of Fisheries, Faculty of Marine Natural Resources, Khorramshahr University of Marine Science and Technology, Khorramshahr, Iran;
A JahediMSc in Aquaculture, Agricultural Jihad Educational Center of Khoozestan, Ahvaz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using probiotics can control pathogens by a variety of mechanisms. Probiotics can promote growth performance and have, therefore, become increasingly important in the aquaculture industry. Convict Cichlid belongs to the family of Cichlidae and is known for its rapid development in laboratory conditions and is suitable for behavioral examinations. The aim of this study was to evaluate the effects of Saccharomyces cerevisiae on growth performance, survival rate and body composition of Convict Cichlids (Amatitlania nigrofasciata). One hundred sixty eight Convict Cichlids (mean weight: 2.1 ± 0.12 g and mean length: 2.2 ± 0.05 cm) were fed by commercial diets with different concentrations of S. cerevisiae (0, 0.5%, 1%, 2%). At the end of the experiment, survival rate and growth indices were measured. Based on the results, growth performance significantly increased with probiotic, S. cerevisiae, specially, at the 2% probiotic level of concentration. In the present study, the best FCR (feed conversion rate), SGR (specific growth rate), CF (condition factor) and BWG (body weight gain) values were observed in a 2% concentration of S. cerevisiae. The results suggest that this yeast could improve feed utilization in this fish species.

Indexed as

Amatitlania nigrofasciataConvict CichlidGrowth performanceProbioticSaccharomyces cerevisiae

Identifiers

PMID27175152
PMCPMC4789241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.